| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| SLC15A1 |
3-(2-Aminopropanoylamino)propanoic acid |
2700000 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
Phenylalanylsarcosine |
210000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| SLC15A1 |
[(2R,3S,4R)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2S)-2-amino-3-methylbutanoate |
NA |
166000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
[(2R,3S,4R)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2S)-2-amino-3-(4-chlorophenyl)propanoate |
NA |
142000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
[(2R,3S,4R)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2S)-2,6-diaminohexanoate |
NA |
477000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
[(2R,3S,4R)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2S)-pyrrolidine-2-carboxylate |
NA |
537000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
[(2R,3S,4R)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2S)-2-amino-3-(4-methoxyphenyl)propanoate |
NA |
300000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
(3R)-3-amino-4-[[(2R,3S,4R)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-4-oxobutanoic acid |
NA |
421000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
[(2R,3S,4R)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2S)-2-amino-3-phenylpropanoate |
NA |
218000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
[(2R,3S,4R)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2R)-2-amino-3-methylbutanoate |
NA |
342000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
[(2R,3S,4R)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2R)-2-amino-3-phenylpropanoate |
NA |
282000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
(3S)-3-amino-4-[[(2R,3S,4R)-5-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-4-oxobutanoic acid |
NA |
260000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
Asp-Asp |
NA|410000 |
NA|630000 |
NA |
990000|NA |
NA |
NA |
BindingDB|TTD |
| SLC15A1 |
Moxalactam |
12000000|12300000 |
NA |
NA |
NA |
NA |
NA |
BindingDB|PubChem|TTD |
| SLC15A1 |
Cefadroxil |
NA|1450000|7200000|9100000 |
870000|5400000|NA |
NA |
NA |
NA |
NA |
BindingDB|PubChem|TTD |
| SLC15A1 |
Cefaclor |
NA|10000000 |
8200000|NA |
NA |
NA |
NA |
NA |
BindingDB|PubChem|TTD |
| SLC15A1 |
2-(2-Azaniumylpropanoylamino)acetate |
140000 |
NA |
NA |
NA |
NA |
NA |
BindingDB |
| SLC15A1 |
Ceftibuten |
340000|710000|870000 |
NA |
NA |
NA |
NA |
NA |
BindingDB|PubChem|TTD |
| SLC15A1 |
trans-Cefuroxime |
26000000 |
NA |
NA |
NA |
NA |
NA |
BindingDB |
| SLC15A1 |
Cefodizime |
22000000 |
NA |
NA |
NA |
NA |
NA |
BindingDB|PubChem|TTD |